Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients

The BRCA1/2 germline and/or somatic pathogenic variants (PVs) are key players in the hereditary predisposition and therapeutic response for breast, ovarian and, more recently, pancreatic and prostate cancers. Aberrations in other genes involved in homologous recombination and DNA damage response (DD...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmasso, Bruna, Puccini, Alberto, Catalano, Fabio, Borea, Roberto, Iaia, Maria Laura, Bruno, William, Fornarini, Giuseppe, Sciallero, Stefania, Rebuzzi, Sara Elena, Ghiorzo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099822/
https://www.ncbi.nlm.nih.gov/pubmed/35563100
http://dx.doi.org/10.3390/ijms23094709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099822/
https://www.ncbi.nlm.nih.gov/pubmed/35563100
http://dx.doi.org/10.3390/ijms23094709

Ejemplares similares